Analysis of commercial claims data covering approximately 50 million insured lives found GLP-1 users experienced: 44% fewer major cardiovascular-related hospitalizations 69% improvement in medical spend growth among diabetes-related GLP-1 users over 30 months 37% improvement in medical spend growth among weight-loss GLP-1 users over 18 months Researchers have also observed positive trends related to inflammatory conditions, cardiovascular disease, and other chronic health concerns
Oral semaglutide drops Oral semaglutide drops represent a newer delivery method
Either way, consult your healthcare provider before starting any new supplement
The Benjamini-Hochberg method was used to adjust p-values for multiple testing, controlling the false discovery rate (FDR)
The growing incidence of diabetes among Indians, as in the world, is a relatively recent phenomenon and is probably the result of lifestyle changes associated with over-nutrition
After a drug is approved and used by the public, more data is collected through whats called post-marketing reports